Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention
BMC Medical Informatics and Decision Making · 2024
DOI: 10.1186/s12911-024-02434-1 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift BMC Medical Informatics and Decision Making, 2024. Verfasst von Liza G G van Lent und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands. l.vanlent@erasmusmc.nl. Hauptthemen laut MEDLINE: Decision Making, Neoplasms. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Kankerbestrijding.
Abstract (Originalsprache)
Background
Patients with advanced cancer who no longer have standard treatment options available may decide to participate in early phase clinical trials (i.e. experimental treatments with uncertain outcomes). Shared decision-making (SDM) models help to understand considerations that influence patients’ decision. Discussion of patient values is essential to SDM, but such communication is often limited in this context and may require new interventions. The OnVaCT intervention, consisting of a preparatory online value clarification tool (OnVaCT) for patients and communication training for oncologists, was previously developed to support SDM. This study aimed to qualitatively explore associations between patient values that are discussed between patients and oncologists during consultations about potential participation in early phase clinical trials before and after implementation of the OnVaCT intervention.
Methods
This study is part of a prospective multicentre nonrandomized controlled clinical trial and had a between-subjects design: pre-intervention patients received usual care, while post-intervention patients additionally received the OnVaCT. Oncologists participated in the communication training between study phases. Patients’ initial consultation on potential early phase clinical trial participation was recorded and transcribed verbatim. Applying a directed approach, two independent coders analysed the transcripts using an initial codebook based on previous studies. Steps of continuous evaluation and revision were repeated until data saturation was reached.
Results
Data saturation was reached after 32 patient-oncologist consultations (i.e. 17 pre-intervention and 15 post-intervention). The analysis revealed the values: hope, perseverance, quality or quantity of life, risk tolerance, trust in the healthcare system/professionals, autonomy, social adherence, altruism, corporeality, acceptance of one’s fate, and humanity. Patients in the pre-intervention phase tended to express values briefly and spontaneously. Oncologists acknowledged the importance of patients’ values, but generally only gave ‘contrasting’ examples of why some accept and others refuse to participate in trials. In the post-intervention phase, many oncologists referred to the OnVaCT and/or asked follow-up questions, while patients used longer phrases that combined multiple values, sometimes clearly indicating their weighing.
Conclusions
While all values were recognized in both study phases, our results have highlighted the different communication patterns around patient values in SDM for potential early phase clinical trial participation before and after implementation of the OnVaCT intervention. This study therefore provides a first (qualitative) indication that the OnVaCT intervention may support patients and oncologists in discussing their values.
Trial registration
Netherlands Trial Registry: NL7335, registered on July 17, 2018.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands. l.vanlent@erasmusmc.nl.
- Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.
- Department of Medical Oncology, UMC Utrecht Cancer Centre, Utrecht, the Netherlands.
- Department of Medical Oncology and Clinical Pharmacology, Antoni Van Leeuwenhoek, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Pain, Anaesthesiology and Palliative Care, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of IQ Healthcare, Radboud University Medical Centre, Nijmegen, the Netherlands.
ORCID-Profile: Liza G G van Lent, Mirte van der Ham, Maja J A de Jonge, Eelke H Gort, Jeroen Hasselaar, Carin C D van der Rijt, Jelle van Gurp, Julia C M van Weert
Förderung
- KWF Kankerbestrijding
Zitieren
APA
van Lent, L. G. G., van der Ham, M., de Jonge, M. J. A., Gort, E. H., van Mil, M., Hasselaar, J., van der Rijt, C. C. D., van Gurp, J., & van Weert, J. C. M. (2024). Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-024-02434-1
Vancouver
van Lent LGG, van der Ham M, de Jonge MJA, Gort EH, van Mil M, Hasselaar J, et al. Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention. BMC Medical Informatics and Decision Making. 2024. doi:10.1186/s12911-024-02434-1
BibTeX
@article{vanLent2024,
author = {van Lent, Liza G G and van der Ham, Mirte and de Jonge, Maja J A and Gort, Eelke H and van Mil, Marjolein and Hasselaar, Jeroen and van der Rijt, Carin C D and van Gurp, Jelle and van Weert, Julia C M},
title = {Patient values in patient-provider communication about participation in early phase clinical cancer trials: a qualitative analysis before and after implementation of an online value clarification tool intervention},
journal = {BMC Medical Informatics and Decision Making},
year = {2024},
doi = {10.1186/s12911-024-02434-1}
}
EUVIMED